Addendum: Amadori, S., et al. Experimental Evaluation and Modeling of the Damping Properties of Multi-Layer Coated Composites. Coatings 2018, 8, 53

Autor: Angelo Casagrande, Giuseppe Catania, Stefano Amadori

Publikováno v: Coatings, Vol 8, Iss 7, p 242 (2018)

We wish to add the following statement to the published article [1].[...]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ddc743e1097ed2d6047434a43f5d569
https://doi.org/10.3390/coatings8070242

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.

Autor: Baron F; Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Laboratory of Hematology, University of Liège, Liège, Belgium., Efficace F; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy., Cannella L; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy., Stevens-Kroef M; Radboud University Medical Center, Nijmegen, The Netherlands., Amadori S; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy., de Witte T; Radboud University Medical Center, Nijmegen, The Netherlands., Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Venditti A; Department of Hematology, Sapienza University, Rome, Italy., Suciu S; EORTC Headquarters, Brussels, Belgium.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 486-489. Date of Electronic Publication: 2024 Jan 04.

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.

Autor: Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany. Electronic address: michael.luebbert@uniklinik-freiburg.de., Wijermans PW; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands., Kicinski M; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Chantepie S; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France., Van der Velden WJFM; Department of Hematology, Radboud University, Nijmegen, Netherlands., Noppeney R; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany., Griškevičius L; Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Gießen and Marburg, Campus Marburg, Marburg, Germany., Crysandt M; Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany., Vrhovac R; Department of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia., Luppi M; Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, University of Modena and Reggio Emilia, Azienda Ospedaliera Universitaria, Modena, Italy., Fuhrmann S; Department of Hematology and Oncology, Helios Hospital Berlin-Buch, Kiel, Germany., Audisio E; Department of Haematology, Azienda Ospedaliera Città della Salute e della Scienza di Torino-Ospedale Molinette, Torino, Italy., Candoni A; Clinica Ematologica Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy., Legrand O; Service d'Hématologie Clinique et de Thérapie cellulaire, Hôpital Saint Antoine, APHP, Paris, France., Foà R; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Università di Roma, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., van Lammeren-Venema D; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, Netherlands., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands., Giraut A; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Stevens-Kroef M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Jansen JH; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., de Graaf AO; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Ammatuna E; University Medical Center Groningen, Groningen, Netherlands., Vilque JP; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France., Wäsch R; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany., Blijlevens N; Department of Hematology, Radboud University, Nijmegen, Netherlands., Dührsen U; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany., Baron F; GIGA-I3 and Centre Hospitalier Universitaire, University of Liège, Liège, Belgium., Suciu S; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Amadori S; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Venditti A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Huls G; University Medical Center Groningen, Groningen, Netherlands. Electronic address: g.huls@umcg.nl.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2023 Nov; Vol. 10 (11), pp. e879-e889.

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Autor: Jahn N; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Jahn E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Saadati M; Saadati Solutions, Ladenburg, Germany., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité University, Berlin, Germany., Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA., Ottone T; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.; Santa Lucia Foundation, Neuro-Oncohematology, I.R.C.C.S., Rome, Italy., Amadori S; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Prior TW; Case Western Reserve University, Cleveland, OH, USA., Brandwein JM; Department of Medicine, University of Alberta, Edmonton, AB, Canada., Appelbaum FR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Medeiros BC; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA, USA., Tallman MS; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ehninger G; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Pallaud C; Novartis Pharmaceuticals, Basel, Switzerland., Gathmann I; Novartis Pharmaceuticals, Basel, Switzerland., Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Thiede C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany., Stone RM; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. konstanze.doehner@uniklinik-ulm.de.

Publikováno v: Leukemia [Leukemia] 2022 Sep; Vol. 36 (9), pp. 2218-2227. Date of Electronic Publication: 2022 Aug 03.